FOLLICULAR LYMPHOMA
Clinical trials for FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early-Stage trial tests immune therapy for untreated lymphoma
Disease control TerminatedThis study tested whether pembrolizumab, an immunotherapy drug, could help control certain slow-growing B-cell lymphomas in people who hadn't yet received any treatment. The goal was to see if boosting the body's immune system could attack the cancer cells. The trial was stopped …
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo tested to control blood cancers in First-Time patients
Disease control TerminatedThis study tested a two-drug combination as the first treatment for people newly diagnosed with certain slow-growing blood cancers called follicular lymphoma or marginal zone lymphoma. The goal was to see if adding the experimental drug umbralisib to the approved drug rituximab c…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC